1. Home
  2. CASI vs JZ Comparison

CASI vs JZ Comparison

Compare CASI & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CASI Pharmaceuticals Inc.

CASI

CASI Pharmaceuticals Inc.

HOLD

Current Price

$0.91

Market Cap

24.9M

Sector

Health Care

ML Signal

HOLD

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

N/A

Current Price

$1.40

Market Cap

3.9M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CASI
JZ
Founded
1991
2011
Country
China
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
24.9M
3.9M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
CASI
JZ
Price
$0.91
$1.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
34.8K
5.8K
Earning Date
11-14-2025
10-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$26,846,000.00
$6,589,020.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.72
N/A
52 Week Low
$0.80
$1.30
52 Week High
$3.47
$14.60

Technical Indicators

Market Signals
Indicator
CASI
JZ
Relative Strength Index (RSI) 30.73 40.30
Support Level $0.80 $1.38
Resistance Level $0.97 $1.44
Average True Range (ATR) 0.09 0.02
MACD 0.00 0.01
Stochastic Oscillator 14.10 25.00

Price Performance

Historical Comparison
CASI
JZ

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: